RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
1.110
-0.050 (-4.31%)
At close: Apr 3, 2025, 4:00 PM
1.130
+0.020 (1.80%)
Pre-market: Apr 4, 2025, 9:25 AM EDT
RAPT Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RAPT Therapeutics stock have an average target of 5.00, with a low estimate of 2.00 and a high estimate of 10. The average target predicts an increase of 350.45% from the current stock price of 1.11.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for RAPT Therapeutics stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 1 | 1 |
Hold | 7 | 6 | 6 | 6 | 4 | 4 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 10 | 10 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +800.90% | Mar 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | +800.90% | Dec 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 25, 2024 |
Wells Fargo | Wells Fargo | Buy Maintains $17 → $4 | Buy | Maintains | $17 → $4 | +260.36% | Nov 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.61
from -3.19
EPS Next Year
-0.70
from -0.61
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.36 | -0.38 | -0.36 | ||
Avg | -0.61 | -0.70 | -0.35 | ||
Low | -0.74 | -0.89 | -0.33 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.